Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

BACKGROUND: Current radiological assessments of (18)fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information regarding disease burden and organ involvement, and hinder the use of FDG-PET...

Descripción completa

Detalles Bibliográficos
Autores principales: Jemaa, S., Paulson, J. N., Hutchings, M., Kostakoglu, L., Trotman, J., Tracy, S., de Crespigny, A., Carano, R. A. D., El-Galaly, T. C., Nielsen, T. G., Bengtsson, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373298/
https://www.ncbi.nlm.nih.gov/pubmed/35962459
http://dx.doi.org/10.1186/s40644-022-00476-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373298/
https://www.ncbi.nlm.nih.gov/pubmed/35962459
http://dx.doi.org/10.1186/s40644-022-00476-0

Ejemplares similares